Universal genotyping in tuberculosis control program, New York City, 2001-2003

In 2001, New York City implemented genotyping to its tuberculosis (TB) control activities by using IS6110 restriction fragment length polymorphism (RFLP) and spoligotyping to type isolates from culture-positive TB patients. Results are used to identify previously unknown links among genotypically cl...

Full description

Saved in:
Bibliographic Details
Published inEmerging infectious diseases Vol. 12; no. 5; pp. 719 - 724
Main Authors Clark, Carla M, Driver, Cynthia R, Munsiff, Sonal S, Driscoll, Jeffrey R, Kreiswirth, Barry N, Zhao, Benyang, Ebrahimzadeh, Adeleh, Salfinger, Max, Piatek, Amy S, Abdelwahab, Jalaa
Format Journal Article
LanguageEnglish
Published United States U.S. National Center for Infectious Diseases 01.05.2006
Centers for Disease Control and Prevention
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In 2001, New York City implemented genotyping to its tuberculosis (TB) control activities by using IS6110 restriction fragment length polymorphism (RFLP) and spoligotyping to type isolates from culture-positive TB patients. Results are used to identify previously unknown links among genotypically clustered patients, unidentified sites of transmission, and potential false-positive cultures. From 2001 to 2003, spoligotype and IS6110-based RFLP results were obtained for 90.7% of eligible and 93.7% of submitted isolates. Fifty-nine (2.4%) of 2,437 patient isolates had false-positive culture results, and 205 genotype clusters were identified, with 2-81 cases per cluster. Cluster investigations yielded 57 additional links and 17 additional sites of transmission. Four additional TB cases were identified as a result of case finding initiated through cluster investigations. Length of unnecessary treatment decreased among patients with false-positive cultures.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1080-6040
1080-6059
DOI:10.3201/eid1205.050446